anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

213,961-214,020 of 319,975

filter-aware
07
The slide uses a horizontal timeline to track progress against specific technical and production milestones.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · SolutionLoop · Zoom In1 hit
08
Uses a process flow diagram to explain the capital-light manufacturing strategy.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · SolutionLoop · Zoom In1 hit
09
The slide uses a stacked bar chart to illustrate cost structure and contribution margin for different fuel cell configurations.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · SolutionLoop · Zoom In1 hit
10
Uses stacked bar charts to illustrate cost and working capital reduction.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations 1 hit
11
The chart shows that at 1,000 units, FCEV cost without subsidy ($1.33) is approaching diesel parity ($1.31).Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations 1 hit
12
The slide outlines a progression from Pilot to Ramp-up, detailing truck counts and hydrogen consumption.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Market Size1 hit
13
The slide uses a funnel-like progression from early engagement to contracted fleets, highlighting specific anchor customers.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Market Size1 hit
14
The slide uses two distinct visual comparisons: a bar-style timeline for refueling and a bubble-chart style comparison for payload efficiency.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Market Size1 hit
15
The slide uses a combination of infographic icons for load comparison and a bar chart for infrastructure requirements.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations 1 hit
16
Hyzon | Investor Conference Presentation Deck | 24 slidesHyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations 1 hit
17
Features two photos of the same truck model in different environments (indoor facility and outdoor track).Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations 1 hit
18
The chart uses a waterfall-like structure to aggregate market segments into a total addressable market.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations 1 hit
19
The table uses checkmarks to indicate capability/applicability across different feedstock types (MSW, RNG, Industrial Gas, Biomass, Solar/Wind).Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations 1 hit
20
Hyzon | Investor Conference Presentation Deck | 24 slidesHyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
21
The table includes revenue, operating expenses, net income, EPS, Adjusted EBITDA, CapEx, cash position, and headcount.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
22
The table provides a detailed breakdown of non-GAAP financial adjustments.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
23
Includes a footnote regarding the exclusion of $8.4 million Orten acquisition cancellation in 3Q 2022.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
24
Includes footnotes regarding legal contingencies and SEC settlements.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
01
Slide 1
Hyzon | Results Presentation Deck | 19 slidesHyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations 1 hit
02
Hyzon | Results Presentation Deck | 19 slidesHyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations 1 hit
03
Includes both operational milestones and financial results/guidance.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Humble Origins1 hit
04
Hyzon | Results Presentation Deck | 19 slidesHyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Humble Origins1 hit
05
The slide uses a three-row structure to categorize company assets: technology, product, and ecosystem.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Humble Origins1 hit
06
The slide uses a process-like flow to connect technical features to quantitative performance outcomes.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Early Struggles1 hit
07
The slide uses a horizontal timeline to track progress against specific technical and production milestones.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Early Struggles1 hit
08
The slide uses a funnel-like progression for the pipeline and highlights specific customer logos under the 'Contracted Fleets' stage.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Rising Success1 hit
09
Uses a process flow diagram to illustrate the transition from subassembly modules to final assembly and customer experience.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Rising Success1 hit
10
The slide outlines a strategic progression from pilot to full ramp-up, supported by specific operational metrics.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Rising Success1 hit
11
Uses a map-based layout to associate product types with regional progress.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Rising Success1 hit
12
The slide uses icons to categorize milestones into Organization, Fuel cell, and Vehicle.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Rising Success1 hit
13
The slide uses a matrix-like structure to map strategic initiatives against time and recurrence.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · The Breakthrough1 hit
14
Hyzon | Results Presentation Deck | 19 slidesHyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
15
The table includes both GAAP financial metrics and supplemental non-GAAP/operational data.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
16
The data shows a significant spike in legal/consulting/accounting fees in Q2 2023 due to SEC investigation accruals.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
17
The table includes footnotes explaining specific adjustments to the figures.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
18
Hyzon | Results Presentation Deck | 19 slidesHyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
19
The table includes adjustments for fair value changes, stock-based compensation, and legal/regulatory matters.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
01
Slide 1
Immix Biopharma | Investor Presentation Deck | 46 slidesImmix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
02
Immix Biopharma | Investor Presentation Deck | 46 slidesImmix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
03
The slide highlights two distinct pipelines: TSTx (Tissue Specific Therapeutics) and NextGen CAR-T.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
04
The slide uses a wave-like visual to represent market segments and their associated financial opportunities.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and therapy type (CAR-T vs TSTx).Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
The slide uses a grouped bar chart to compare clinical outcomes across different patient segments (No BCMA, Yes BCMA, Overall).Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
Includes detailed source citations in the footer.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
08
Includes detailed source citations in the footer.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a side-by-side comparison of two proprietary technology platforms.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
11
Immix Biopharma | Investor Presentation Deck | 46 slidesImmix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
12
The slide uses a matrix structure to compare clinical outcomes against three key value propositions.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
13
Includes comparative bar charts and flow cytometry data.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
14
Includes a comparison table of clinical outcomes (ORR/CR) for NXC-201 vs competitors.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
15
Immix Biopharma | Investor Presentation Deck | 46 slidesImmix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
16
The slide compares two disease indications side-by-side with clinical metrics and competitive market context.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
17
The table uses a red dashed box to highlight the key clinical data rows (ORR, CR, ICANS, CRS).Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
18
The chart demonstrates deepening clinical responses over time, a key indicator of therapeutic efficacy in oncology trials.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
19
The slide uses a red dashed box to highlight the key efficacy metrics for comparison.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
20
The table displays clinical trial data for NXC-201, including toxicity management metrics like Tocilizumab and Dexamethasone usage.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
21
The slide highlights specific safety data points for two dosage groups (100x10^6 and 300x10^6 cells).Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
22
The slide uses a structured table-like layout to map clinical progress against specific disease indications.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
23
The diagram illustrates a dose escalation process leading to the RP2D.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit